Acknowledging "constructive" trade consultations between China and the U.S., the Trump administration over the weekend stepped back from calling for tariffs on a long list of imports from China, including drugs and medical devices. While it made no specific mention of drugs and devices, a joint statement issued by the trade delegations from China and the U.S. said they have reached a consensus on taking effective measures to "substantially reduce" the U.S. trade deficit in goods with China.